Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques

The European Medicines Agency received recently the first marketing authorization application for a biosimilar monoclonal antibody (mAb) and adopted the final guidelines on biosimilar mAbs and Fc-fusion proteins. The agency requires high similarity between biosimilar and reference products for appro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ayoub, Daniel, Jabs, Wolfgang, Resemann, Anja, Evers, Waltraud, Evans, Catherine, Main, Laura, Baessmann, Carsten, Wagner-Rousset, Elsa, Suckau, Detlev, Beck, Alain
Formato: Artigo
Idioma:Inglês
Publicado em: Landes Bioscience 2013
Assuntos:
Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3851223/
https://ncbi.nlm.nih.gov/pubmed/23924801
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/mabs.25423
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados